| CXHS2300088 | 维派那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2023-09-26 | | | | | view |
| CXHB1700049 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs | Supplementary Application | 2017-06-08 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | Certificate Issued | 2017-10-17 | view |
| CXHL2101223 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-06-25 | | Peg BIO Co Ltd | | | view |
| CXHL1200115 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1.1) | New Drug Application | 2012-04-28 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | Certificate Issued | 2013-09-13 | view |
| CXHB2000061 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs | Supplementary Application | 2020-06-29 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | In Review | 2020-06-28 | view |
| CXHL2100209 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-03-27 | 派格生物医药（苏州）股份有限公司 | Peg BIO Co Ltd | In Review | 2021-03-26 | view |
| CXHB2400043 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | Supplementary Application | 2024-02-19 | | Peg BIO Co Ltd | | | view |
| JYHB2200688 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | | | | view |
| JYHB1000609 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Supplementary Application | 2010-07-22 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia | Certificate Issued | 2011-02-21 | view |
| JYHB1901370 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Supplementary Application | 2019-11-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-02-14 | view |
| CXHS1400179 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(3.1) | New Drug Application | 2014-07-25 | 青海晨菲制药有限公司 | Qinghai Chenfei Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
| JXHL0500069 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(1.1) | Import Drug Application | 2005-04-21 | | Eli Lilly & Company | Certificate Issued | 2005-12-27 | view |
| JXHL1700082 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(2.4) | Import Drug Application | 2017-04-21 | 昆泰企业管理（上海）有限公司 | Aikunwei Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2017-07-26 | view |
| JXHL0900098 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Import Drug Application | 2009-04-09 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2010-02-09 | view |
| JYHZ1800247 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | License Renew | 2018-08-15 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-01-04 | view |
| JYHB1301512 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Supplementary Application | 2013-12-02 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2014-07-31 | view |
| JYHB2001204 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-07-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-08-17 | view |
| CYHS1500793 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(6) | Generic Drug | 2015-07-08 | 长春百益制药有限责任公司 | Changchun Baiyi Pharmaceutical Co Ltd | Certificate Issued | 2021-04-08 | view |
| JXHL0700307 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(3.1) | Import Drug Application | 2007-11-06 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2009-05-20 | view |
| CYHS1700279 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2018-08-22 | 青海晨菲制药有限公司 | Qinghai Chenfei Pharmaceutical Co Ltd | In Review | 2018-08-20 | view |
